Gabriela Studer

Head And Neck Surgery
Zurich, ZH, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 102 publications

Local Recurrence and Metastasis Define Distinct Recurrence Phenotypes in Soft Tissue Sarcoma.

Local Recurrence and Metastasis Define Distinct Recurrence Phenotypes in Soft Tissue Sarcoma.

Journal: Cancers
Published: May 17, 2026

Twelve-Month Metastatic State as a Landmark-Based Prognostic Stratifier in Metastatic Sarcoma.

Twelve-Month Metastatic State as a Landmark-Based Prognostic Stratifier in Metastatic Sarcoma.

Journal: Cancers
Published: April 12, 2026

Locked-Window EQ-5D-5L (Index and VAS) Benchmarking in Sarcoma Care: Rule-Based Traffic-Light Classification Across Two Institutions.

Locked-Window EQ-5D-5L (Index and VAS) Benchmarking in Sarcoma Care: Rule-Based Traffic-Light Classification Across Two Institutions.

Journal: Diseases (Basel, Switzerland)
Published: April 01, 2026

From Network Governance to Real-World-Time Learning: A High-Reliability Operating Model for Rare Cancers.

From Network Governance to Real-World-Time Learning: A High-Reliability Operating Model for Rare Cancers.

Journal: Cancers
Published: January 26, 2026

Organizing Care Matters: Fragmented Pathways Double Early Local Recurrence Risk in Sarcoma.

Organizing Care Matters: Fragmented Pathways Double Early Local Recurrence Risk in Sarcoma.

Journal: Cancers
Published: December 30, 2025

Value operating system: a practical framework to measure outcomes-per-cost at the episode level.

Value operating system: a practical framework to measure outcomes-per-cost at the episode level.

Journal: BMJ open quality
Published: December 18, 2025

Reporting Matters: Severe Adverse Events in Soft Tissue Sarcoma Therapy-A 30-Year Systematic Review of Placebo- and Non-Systemic-Controlled Randomized Trials.

Reporting Matters: Severe Adverse Events in Soft Tissue Sarcoma Therapy-A 30-Year Systematic Review of Placebo- and Non-Systemic-Controlled Randomized Trials.

Journal: Cancers
Published: August 18, 2025

Triangulating Timing, Tropism and Burden of Sarcoma Metastases: Toward Precision Surveillance and Therapy in a Real-World-Time Cohort.

Triangulating Timing, Tropism and Burden of Sarcoma Metastases: Toward Precision Surveillance and Therapy in a Real-World-Time Cohort.

Journal: Cancers
Published: August 11, 2025

Diagnosis-Related Outcome Following Palliative Spatially Fractionated Radiation Therapy (Lattice) of Large Tumors.

Diagnosis-Related Outcome Following Palliative Spatially Fractionated Radiation Therapy (Lattice) of Large Tumors.

Journal: Cancers
Published: July 27, 2025

A comparative cost analysis of 25-fraction vs 5-fraction postoperative radiotherapy regimens for breast cancer.

A comparative cost analysis of 25-fraction vs 5-fraction postoperative radiotherapy regimens for breast cancer.

Journal: Swiss medical weekly
Published: June 26, 2025

Rethinking the Prognostic Role of Necrosis in Soft-Tissue Sarcoma: Multidisciplinary Insights from the Sarcoma Academy.

Rethinking the Prognostic Role of Necrosis in Soft-Tissue Sarcoma: Multidisciplinary Insights from the Sarcoma Academy.

Journal: Cancers
Published: April 06, 2025

From Intensification to Optimization: Balancing Efficacy, Safety, and Costs in High-Risk Localized Soft Tissue Sarcomas.

From Intensification to Optimization: Balancing Efficacy, Safety, and Costs in High-Risk Localized Soft Tissue Sarcomas.

Journal: Cancers
Published: March 14, 2025
Showing 1-12 of 102

Last Updated: 09/26/2026